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ABSTRACT 
Glucose administration is associated with memory enhancement in healthy young individuals 
under conditions of divided attention at encoding. While the specific neurocognitive 
mechanisms underlying this ‘glucose memory facilitation effect’ (GMFE) are currently 
uncertain, it is thought that individual differences in glucoregulatory efficiency may alter an 
individual’s sensitivity to the GMFE. In the present study, we sought to investigate whether 
basal hypothalamic-pituitary-adrenal (HPA) axis function (itself a modulator of 
glucoregulatory efficiency), baseline self-reported stress and trait anxiety influence the 
GMFE. Adolescent males (age range = 14-17 years) were administered glucose and placebo 
prior to completing a verbal episodic memory task on two separate testing days in a counter-
balanced, within subjects design. Glucose ingestion improved verbal episodic memory 
performance when memory recall was tested a) within an hour of glucose ingestion and 
encoding and b) one week subsequent to glucose ingestion and encoding. Basal HPA axis 
function did not appear to influence the GMFE, however glucose ingestion only improved 
memory in participants reporting relatively higher trait anxiety. These findings suggest that 
the GMFE may be mediated by biological mechanisms associated with trait anxiety.  
 
Keywords: episodic memory, glucose, glucoregulation, HPA axis, trait anxiety, adolescents 
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INTRODUCTION 
 The ingestion of oral glucose is associated with enhanced performance in a range of 
cognitive domains, including verbal episodic memory (Foster et al., 1998), working memory 
(Martin and Benton, 1999), executive functioning (Donohoe and Benton, 1999), reaction time 
(Owens and Benton, 1994), serial subtraction (Kennedy and Scholey, 2000; Scholey et al., 
2001) and attention (Benton et al., 1994). Glucose has only been observed to reliably improve 
verbal episodic memory performance in healthy young adults when encoding of memory 
materials takes place under conditions of divided attention (Foster et al., 1998; Sünram-Lea et 
al., 2001, 2002b). Recent studies from our laboratory suggest that this ‘glucose memory 
facilitation effect’ (GMFE) can be extended to healthy adolescent participants (Smith and 
Foster, 2008a; Smith and Foster, 2008b; Smith et al., in press). It is of interest to further 
investigate the role of glucose in the mediation of cognitive performance in this age group, 
given that the basal cerebral metabolic rate of children and adolescents is typically higher 
than adults (Chiron et al., 1992). 
Previous research findings have suggested that individual differences in 
glucoregulatory efficiency may modulate this enhancing effect of glucose on memory (for 
reviews see Messier, 2004; Riby and Riby, 2006; Gibson, 2007). However, the direction of 
the relationship between glucoregulatory efficiency and glucose facilitation of memory 
remains uncertain, with some studies reporting that a memory benefit is more likely in 
individuals with poorer glucoregulatory efficiency subsequent to glucose ingestion (Hall et 
al., 1989; Craft et al., 1994; Messier et al., 1999; Kaplan et al., 2000; Messier et al., 2003), 
while other studies have reported that individuals exhibiting relatively better glucoregulatory 
efficiency are more amenable to the GMFE (Craft et al., 1994; Messier et al., 1997; Meikle et 
al., 2004; Riby et al., 2004; Smith and Foster, 2008a). While age is believed to influence the 
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relationship between glucoregulatory efficiency and the GMFE (Craft et al., 1994; Smith and 
Foster, 2008a), the specific mechanisms underlying this relationship are not well understood.  
 Altered glucoregulatory efficiency has been associated with symptoms of 
hypothalamic-pituitary-adrenal (HPA) axis dysfunction (Plat et al., 1996; Reynolds et al., 
2001; Andrews et al., 2002; Gibson, 2007). HPA activation in response to acute stress leads 
to the release of cortisol, the primary glucocorticoid hormone in humans. Increased cortisol 
secretion from the adrenal gland is associated with an elevation in circulating blood glucose 
concentration (Newton, 2000). Likewise, adrenaline release in response to acute stress, which 
is subserved by the sympathetic-adrenal medullary (SAM) axis, enables the rapid liberation 
of glucose in to the bloodstream (Gold, 1995). Endogenous (e.g. Cahill et al., 2003; Smeets et 
al., 2006; Duncko et al., 2007; Nater et al., 2007), as well as exogenous (e.g. Buchanan and 
Lovallo, 2001; Lupien et al., 2002; Abercrombie et al., 2003; Kuhlmann and Wolf, 2006) 
increases in cortisol have been demonstrated to facilitate memory performance, but many 
factors are known to modulate this relationship, including a) whether the stressor is related to 
the to-be-remembered stimulus (Joels et al., 2006), b) whether cortisol levels are increased 
prior to encoding or retrieval (Roozendaal, 2002; Joels et al., 2006), c) the emotionality of the 
to-be-remembered stimulus (Buchanan and Lovallo, 2001; Jelicic et al., 2004; Payne et al., 
2007), and d) the time of day (Het et al., 2005). HPA axis mediation of glucose regulation 
likely evolved to enable a rapid supply of energy necessary for coping with an acute stressor 
(Peters et al., 2004). However, HPA axis function can become compromised due to 
gene/environment interactions involving the presence of glucocorticoid or mineralocorticoid 
receptor polymorphisms and frequent or prolonged exposure to life stress (de Kloet et al., 
2005; DeRijk and de Kloet, 2008). Normal HPA axis functioning is crucial in terms of its role 
in regulating blood glucose (Peters et al., 2004), rendering individuals predisposed to HPA 
axis dysfunction at risk for glucoregulatory abnormalities. 
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 On a related note, a number of studies have reported a memory enhancement effect 
for negative emotionally arousing stimuli (Hamann, 2001). Given that adrenaline cannot 
cross the blood-brain barrier (Wenk, 1989; Gold, 1995), it has been suggested that stress 
hormones (including adrenaline and cortisol) may mediate this emotional enhancement 
effect, at least in part by increasing circulating blood glucose concentration (Brandt et al., 
2006). Accordingly, an association has been reported between exposure to emotionally 
arousing stimuli and elevations in blood glucose concentration (Parent et al., 1999; Blake et 
al., 2001; Scholey et al., 2006). However, the relationship between blood glucose 
concentration and emotional memory is complex, given that some studies have reported a) 
blood glucose increases induced by emotional arousal without memory enhancement 
(Scholey et al., 2006), and b) superior memory for emotionally laden material independent of 
blood glucose changes (Gore et al., 2006).  Some recent studies have attempted to integrate 
the findings related to emotional memory and the GMFE by investigating glucose modulation 
of memory for emotionally arousing stimuli, with extant findings indicating that glucose does 
not further facilitate memory for such items (Ford et al., 2002; Brandt et al., 2006). This may 
be due to a ‘stress hormone threshold’ effect, whereby the level of HPA and/or SAM axis 
excitation in response to acute stress is too high for the exogenous supply of glucose to be 
beneficial in terms of neurocognitive enhancement (Brandt et al., 2006).  It is therefore of 
interest to further investigate the neurohormonal mechanisms which may subserve the 
GMFE, especially in situations where the activation of physiological mechanisms related to 
stress is too great for additional glucose availability to induce observable influences on 
memory performance.    
 Given that a relationship has been demonstrated between glucoregulatory efficiency 
and HPA axis function, it is postulated here that basal HPA axis function may be one 
potential mechanism by which glucoregulatory efficiency exerts an influence on the GMFE. 
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It is therefore of interest to consider experimentally whether individual differences in basal 
HPA axis function may mediate the GMFE in healthy young individuals. On this basis, the 
present study aimed to investigate the influence of i) glucoregulatory efficiency, ii) basal 
HPA axis function and iii) self-ratings of subjective stress and trait anxiety (as subjective 
indicators of basal stress) on the GMFE. Predicated on previous observations from our 
laboratory that glucose improves memory only in adolescents exhibiting relatively better 
glucoregulatory efficiency (Smith and Foster, 2008a), it was hypothesised that verbal 
episodic memory would be enhanced subsequent to oral glucose ingestion only for those 
participants exhibiting relatively better glucoregulatory efficiency and ‘normal’ basal HPA 
axis function. Further, it was expected that those participants reporting lower levels of stress 
and trait anxiety would be more amenable to the GMFE. In addition, previous studies have 
suggested that the GMFE persists when recall is tested 24 hours after treatment and encoding 
(Manning et al., 1992; Manning et al., 1998b; Sünram-Lea et al., 2002a). A supplementary 
aim of the present study was to extend these previous findings by investigating whether oral 
glucose ingestion enhances memory when recall takes place one week post-treatment and 
encoding. 
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MATERIALS AND METHODS 
Participants 
 A total of 58 healthy adolescent males, ranging in age between 14 and 17 years (Mage 
= 15.5, SDage = 1.0) participated in the present study. Participants were recruited from 
secondary schools in Perth, Australia. Three participants reported non-compliance with the 
fasting instructions of the study. These participants were removed from the data set for all 
glucose and memory related analyses to avoid any potential confounds from a ‘second meal 
effect’. An additional 15 participants attended only one testing session, and thus were not 
included in any of the analyses reported here.  Therefore, a total of 40 participants were 
included in the final analyses. 
Ethics approval for the present study was obtained from the Human Research Ethics 
Committee of the University of Western Australia. 
 
Treatment and Design 
A within subjects design was employed for the blood glucose analysis, with two 
within-subjects factors (treatment, time). A within-subjects design was also employed for the 
primary memory analyses, with a single within-subjects factor (treatment). A subsequent 
mixed model design also incorporated a single between-subjects factor (glucoregulatory 
efficiency). Similarly, mixed model designs were also employed to investigate i) baseline 
self-reported adolescent stress, and ii) trait anxiety, with the former incorporating a single 
between-subjects factor (stress) and the latter also incorporating a single between-subjects 
factor (trait anxiety). A further mixed model design also comprised a single between subjects 
factor (basal cortisol). A between-subjects design with a single between subjects factor 
(treatment) was used to compare one-week delayed recall forgetting indices between the two 
treatment conditions. 
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  The glucose treatment consisted of 25 g ‘Glucodin’ Glucose Powder (Boots 
Healthcare Australia Pty Ltd) dissolved in 300 ml water. The placebo treatment comprised 
five ‘Equal’ tablets (10% Aspartame, The Merisant Company) dissolved in 300 ml water. It 
has been reported that this quantity of aspartame is matched in terms of subjective 
‘sweetness’ ratings with 25 g glucose powder when dissolved in 300 ml water (Sünram-Lea 
et al., 2008). Participants attended two test sessions. They were administered one treatment 
(i.e. glucose or placebo) in the first session and the complementary treatment in the second 
session. Treatment order was initially counterbalanced, with 29 of the original 58 participants 
assigned to each treatment order. However, of the 40 participants included in the final 
analyses, 22 participants consumed the glucose treatment in the first testing session and 18 
participants consumed the placebo in the first testing session. 
 
Materials 
 Saliva Sampling Equipment and Free Cortisol Analysis. Saliva samples were 
collected using Salivette tubes (Sarstedt Australia, Mawson Lakes, South Australia). Samples 
were centrifuged at 3,000 rpm for 10 minutes, and stored at -80 degrees Celsius. Awakening 
salivary free cortisol levels were subsequently quantified in duplicate by a commercially 
available radioimmunoassay (RIA) kit (DiaSorin, Stillwater, Minnesota, USA) according to 
the manufacturer’s instructions. All saliva samples were analysed in the same assay to 
eliminate inter-assay variation. The intra-assay coefficient of variation was 4.63%. 
 Adolescent Stress Questionnaire (ASQ). The ASQ (Byrne et al., 2007) was developed 
with Australian adolescents and incorporates 58 items from 10 subscales reflecting various 
dimensions of adolescent stress. Each item lists a potential stressor, and participants are 
required to respond on a five-point Likert scale. A score of 1 is indicative of that particular 
event being perceived as ‘not at all stressful’ (or irrelevant), whereas a score of 5 is indicative 
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of that particular event being perceived as ‘very stressful’ during the past year. A total score 
is calculated by summing together the scores for each of the items. 
 State-Trait Anxiety Inventory (STAI). The STAI (Spielberger, 1983) incorporates two 
20-item subscales, measuring a) state anxiety and b) trait anxiety. For the purposes of the 
present study, only the trait anxiety items of the STAI were administered. The trait anxiety 
subscale of the STAI requires participants to rate how they ‘generally feel’ with respect to 20 
statements on a four-point scale (‘almost never’, ‘sometimes’, ‘often’, ‘almost always’). A 
score of 4 represents the highest level of anxiety for that item. A total score is calculated by 
summing together the scores for each of the items. 
Modified California Verbal Learning Test-II (CVLT-II). The CVLT-II (Delis et al., 
2000) is a test of immediate, short delay and long delay episodic memory for a 16-item 
supraspan word list. The test comprises a standard form and an alternate form, which can be 
used for a repeat testing session. The reliability of the alternate form has been demonstrated, 
with reliability coefficients for immediate, short and long delayed free recall ranging between 
0.72 and 0.79 across the different recall phases of the test (Delis et al., 2000; Strauss et al., 
2006). In the present study, participants were administered one form in the first session, and 
the complementary form in the second session, in a counterbalanced order. The order of 
CVLT-II administration was additionally counterbalanced with treatment order. The modified 
version of the CVLT-II employed in the present study was extended to a list length of 20 
items. The lists comprise five items from each of four semantic categories. The word list was 
recorded on audiocassette and played five times to the participants, with an immediate free 
recall trial following each presentation of this list (List A). Immediately subsequent to the 
fifth immediate free recall trial, an interference list (List B) was played on audiocassette to 
the participants, followed by an immediate free recall trial for List B items. The CVLT-II 
additionally comprises free recall phases and cued recall phases (in which participants are 
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provided with the semantic categories from which the items are drawn, as recall cues) at a 
short and long delay. A further modification to the CVLT-II that was employed in the present 
study involved the addition of a one-week delayed free and cued recall phase, in which recall 
was assessed one-week post-encoding. Details pertaining to the timing of the modified 
CVLT-II recall phases are included in the Procedure section, below (see also Table 1). 
In line with our previous work, participants were required to perform a secondary 
motor task simultaneously with encoding of the modified CVLT-II word lists in order to 
increase the difficulty of the memory task by dividing attention across the two tasks (see 
Sünram-Lea et al., 2002b). Participants were told that performance on the word recall task 
and hand movement task was equally important, and that they should aim to perform equally 
well on both tasks. Participants were also told that their hand movements were being 
recorded by a camcorder, so that the researchers could assess their performance at a later 
time. The camcorder was used to induce compliance with task instructions to perform both 
tasks equally well, although no such recording actually took place. Two different motor 
sequences were performed synchronously with both hands.  Participants were required to 
perform a ‘fist’ – ‘chop’ – ‘slap’ motor sequence in the 2.5 s interval between each of the first 
five items of the modified CVLT-II. Between each of the next five items of the modified 
CVLT-II (i.e. items six to ten), participants were required to perform a ‘back-slap’ – ‘chop’ – 
‘fist’ motor sequence. Participants were then required to revert back to the first ‘fist’ – ‘chop’ 
– ‘slap’ sequence between items 11 and 15, and then back to the second ‘back-slap’ – ‘chop’ 
– ‘fist’ sequence for items 16 to 20. Participants were not informed when to switch from one 
sequence to the other. They therefore had to keep track of when to switch from one sequence 
to the next themselves. 
 Bond-Lader Questionnaire. The modified Bond-Lader scale used here (Bond and 
Lader, 1974) has also been employed in other studies investigating nutrition, mood and 
Glucose enhancement of memory 11 
cognitive functioning (Wesnes et al., 2003; Smith and Foster, 2008a). This instrument 
requires participants to rate their level of ‘alertness’, ‘contentedness’, ‘calmness’ and ‘satiety’ 
on 19 bipolar scales. This version of the Bond-Lader scale has been modified from the 
original via the inclusion of three additional items pertaining to satiety (the original version 
comprised only alertness, contentedness and calmness factors). The ratings were made by 
placing a mark at the relevant point on a 100 mm line, with the end of each line reflecting the 
relevant extremes of the dimension being rated (e.g. ‘alert’ versus ‘drowsy’).  A higher score 
indicates a higher level of the relevant dimension. 
Blood Glucose Equipment. Blood glucose concentration was measured using a 
MediSense Optium Blood Glucose Meter, MediSense Optium Point-of Care Disposable 
Blood Glucose Test Strips and a MediSense Auto-Lancing Device with thin lancets (Abbott 
Diagnostics Division, Doncaster, Victoria, Australia).  One drop of capillary blood was 
obtained from the fingertip of each participant for each measurement of blood glucose using 
the lancing device. The inter-assay variation for this sampling procedure ranges by no more 
than 2.9% to 5.1% (according to manufacturer’s user guide). The validity of this procedure 
has also been demonstrated by the manufacturer (r = 0.96 - 0.98 between this method and the 
laboratory reference method). 
 
Procedure 
Approximately one week prior to the first testing session, written informed consent 
was obtained from participants and their parents. At this time, participants were provided 
with three Salivette tubes, and were asked to obtain a saliva sample, 10 minutes post-
awakening on three separate mornings before the first testing session by chewing on the 
Salivette cotton roll for three minutes. Participants were told not to consume any food or 
drinks prior to collecting the samples. They were also asked to take the samples only on days 
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at which they woke up at their typical time of awakening (i.e. to avoid collecting the samples 
on days when they woke considerably earlier or later than the time that they would normally 
wake up on a typical school day). Participants were required to record the time at which each 
sample was taken. Samples collected outside of the 5-30 minute post-awakening window 
were excluded from that participant’s basal cortisol average. Further, participants were also 
given a copy of the STAI and ASQ at this time, for completion prior to the first testing 
session.   
Participants subsequently attended two testing sessions. They were instructed not to 
consume any food or drink, other than water, from 10:30 pm on the evening prior to each of 
these testing sessions. All test sessions began between 7:30 and 9:00 am. Participants first 
completed the modified Bond-Lader questionnaire, and baseline blood glucose concentrations 
were measured. Immediately following the measurement of blood glucose concentrations, 
participants consumed one of the two treatments. Participants were blind as to the contents of 
the drinks, and were told only that they comprised a “sweet tasting liquid”. Participants were 
allowed 10 minutes to consume their designated treatment. Ten minutes following the 
completion of treatment consumption, blood glucose concentrations were measured and 
participants were administered the modified Bond-Lader questionnaire for the second time. 
Participants then completed the immediate free-recall trials of the modified CVLT-II (List A, 
trials 1-5), followed by the modified CVLT-II interference word list (List B). Motor 
sequences were performed during encoding of each CVLT-II list. Participants were 
subsequently administered the third modified Bond-Lader questionnaire, and a third 
measurement of blood glucose concentration was obtained. Following this, participants 
completed the short delay recall phases of the CVLT-II. Following a short break (10 
minutes), the final measurements of blood glucose concentrations were recorded, and the 
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final administration of the modified Bond-Lader questionnaire was given. The long delay 
recall phases of the CVLT-II were then completed. 
A second testing session was conducted exactly one week after the first testing 
session. The second testing session was identical to the first testing session, except that the 
testing procedure was preceded by a free recall and a cued recall test of the memory items 
from the first testing session. This one-week delayed recall phase was a between-subjects 
comparison, with the treatment administered in the first testing session (glucose or placebo) 
determining whether participants were assigned to the glucose or placebo treatment groups 
for the purposes of statistical analysis. On the second testing occasion, participants were also 
administered the complementary treatment (glucose or placebo) and the complementary 
version of the modified CVLT-II (standard form or alternate form) to that administered in the 
first testing session. For details of the precise timings of each of the events within the study 
protocol, see Table 1.  
 
INSERT TABLE 1 ABOUT HERE 
 
Statistical Analysis 
 Pearson correlation analyses were employed to investigate the relationship between 
mean awakening salivary free cortisol level, ASQ scores and trait anxiety scores. 
 A treatment (glucose, placebo) x time (-10, 10, 40, 60) repeated measures analysis of 
variance (ANOVA) was used to analyse blood glucose data. Likewise, Bond-Lader scores 
were also investigated with a treatment (glucose, placebo) x time (-10, 10, 40, 60) repeated 
measures ANOVA. 
 In terms of the memory analyses, a treatment (glucose, placebo) x trial (1, 2, 3, 4, 5) 
repeated measures ANOVA was employed to analyse the immediate free recall data. Delayed 
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recall analyses (short delay free recall, short delay cued recall, long delay free recall, long 
delay cued recall) were conducted using repeated measures ANOVAs with treatment 
(glucose, placebo) as a single repeated measures factor. 
Further, one-week delayed recall forgetting indices were calculated by subtracting the 
number of items recalled in the one-week delayed free recall phase from the long delay free 
recall phase in the first testing session (free recall), and by subtracting the number of items 
recalled in the one-week delayed cued recall phase from the long delay cued recall phase in 
the first testing session (cued recall). These calculations yielded scores that reflect the total 
number of items ‘forgotten’ in the one week-interval between the first and second testing 
session for each individual. One-week delayed recall forgetting indices were analysed for 
both free and cued recall with a one-way ANOVA, with treatment (glucose, placebo) as a 
single between subjects factor. 
A group of relatively ‘better glucoregulators’ and a group of relatively ‘poorer 
glucoregulators’ was established by calculating the area under the glucose response curve 
(AUC) for each participant on the glucose testing day (for the formula used in this calculation 
see Smith and Foster, 2008a; see also Sünram-Lea et al., 2008), and performing a median 
split on these values (with a higher score indicating poorer glucoregulatory efficiency; better 
≤ 60, poorer ≥ 60.5). The combined influence of treatment and glucoregulatory efficiency on 
the memory outcomes was analysed using a treatment (glucose, placebo) x glucoregulatory 
efficiency (better, poorer) mixed model ANOVA, with repeated measures on the treatment 
factor. 
In order to investigate the influence of basal HPA axis function on the memory 
outcomes, participants were stratified into three groups on the basis of mean awakening 
salivary free cortisol (low, normal, high). These groups were formed by comparing 
awakening free cortisol values against those of a reference sample of 723 adolescents aged 
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between 16.0 and 18.4 years (M=17.1 years) enrolled in the Western Australian Pregnancy 
Cohort (Raine) Study (for details of this cohort see Newnham et al., 1993; Newnham et al., 
2004; Robinson et al., 2008). It is considered appropriate to compare the cortisol values of the 
present study against this reference sample, given that the reference sample live in the same 
area, are similar in age to the present study sample and have their awakening salivary free 
cortisol values quantified using the same methodological approach. Participants exhibiting a 
mean awakening free cortisol value between the 40th and 60th percentile when compared to 
this reference group (mean awakening salivary free cortisol range = 0.80-0.96 g/dl) were 
considered to exhibit awakening free cortisol values within the normal range. Individuals 
exhibiting values lower or higher than this range were considered to fall into the ‘low’ or 
‘high’ awakening free cortisol groups respectively. Assigning participants to three groups in 
this manner is more appropriate than using median splits, as the method used in the present 
study enables the consideration of individuals within the normal range of awakening salivary 
free cortisol levels, as well as those individuals who fall either side of the normal range to be 
considered independently. The combined influence of treatment and basal HPA axis function 
on the memory outcomes was analysed using a treatment (glucose, placebo) x awakening free 
cortisol (low, normal, high) mixed model ANOVA, with repeated measures on the treatment 
factor. 
A group of individuals reporting relatively lower baseline stress and a group of 
individuals reporting relatively higher baseline stress were established for analysis by 
performing a median split on the total ASQ scores (low ≤ 126; high ≥ 129). Likewise, a 
group of adolescents reporting relatively lower trait anxiety and a group with relatively 
higher trait anxiety was established by performing a median split on the trait anxiety scores 
(low ≤ 19; high ≥ 20). The combined influence of treatment and baseline stress on the 
memory outcomes was analysed using a treatment (glucose, placebo) x stress (low, high) 
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mixed model ANOVA, with repeated measures on the treatment factor. Similarly, a treatment 
(glucose, placebo) x trait anxiety (low, high) mixed model ANOVA with repeated measures 
on the treatment factor, was employed to investigate the influence of treatment and trait 
anxiety on the memory outcomes. 
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RESULTS 
Basal HPA Axis Function  
 The mean of the awakening salivary cortisol values was calculated for each 
participant as a measure of basal HPA axis function. Mean awakening free cortisol values 
ranged between 0.45 g/ dl and 2.68 g/ dl within the present study sample. Correlation 
analyses between the mean awakening cortisol level, self-reported stress and trait anxiety 
revealed a significant positive relationship between self-reported stress and trait anxiety (r = -
0.58, p = <.001). The negative relationship between trait anxiety and awakening cortisol 
approached significance (r = -0.26, p = .06). Awakening cortisol and baseline stress were not 
significantly correlated. 
 
INSERT TABLE 1 ABOUT HERE 
 
Blood Glucose Concentration 
A significant treatment x time interaction effect was observed, F(3, 37) = 29.13, p < 
.001, with a large effect size (partial η2 = .70). Planned comparisons revealed that, as 
anticipated, blood glucose concentrations were significantly higher for the glucose condition, 
relative to the placebo condition, 10 minutes, t(39) = 4.76, p < .001, 40 minutes,  t(39) = 8.98, 
p < .001, and 60 minutes, t(39) = 4.48, p < .001, post-treatment delivery. Blood glucose 
concentrations between the glucose and placebo conditions did not differ at baseline, t(39) = 
0.59, n.s. (see Figure 1). 
 
INSERT FIGURE 1 ABOUT HERE 
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Bond-Lader Scale 
Time x treatment interactions failed to reach significance on the alertness, 
contentedness, calmness and satiety subscales of the Bond-Lader questionnaire. 
Modified CVLT-II 
In order to interpret data in a meaningful manner, participants who performed at 
ceiling (i.e. recalled 100% of the to-be remembered items) in either the glucose or placebo 
treatment condition on any given recall phase of the CVLT-II were excluded from the 
analyses for that recall phase.  
 Immediate Free Recall. A significant treatment x trial interaction effect was observed 
F(4, 28) = 3.09, p < .05, with a moderate effect size (partial η2 = .31). Planned comparisons 
revealed that a significantly greater number of items was recalled subsequent to glucose 
ingestion, relative to placebo ingestion, on the fourth trial, t(31) = 2.29, p < .05, and fifth trial, 
t(31) = 2.80, p < .01, of the immediate free recall phase (see Figure 2). 
 
INSERT FIGURE 2 ABOUT HERE 
 
 Delayed Recall. A significantly greater number of items was recalled subsequent to 
glucose ingestion, relative to placebo ingestion on the short delay free recall, F(1, 33) = 5.23, 
p < .05, long delay free recall, F(1, 31) = 5.85, p < .05, and long delay cued recall, F(1, 32) = 
5.40, p < .05, phases of the CVLT-II (see Table 2).  
In terms of the one-week delayed recall data, participants who performed at ceiling in 
either recall phase used to determine the forgetting indices (long delay free recall or one-
week delayed recall) were removed from the forgetting index analyses, analogously to the 
aforementioned CVLT analyses. This yielded a sample size of 35 for the one-week free recall 
analyses (19 in the glucose group, 16 in the placebo group) and a sample size of 34 for the 
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one-week cued recall analyses (18 in the glucose group, 16 in the placebo group). A between-
subjects comparison revealed a trend toward significantly greater forgetting in the placebo 
treatment group relative to the glucose treatment group on one-week delayed free recall, F(1, 
33) = 3.86, p = .06,  but not for cued recall (see Figure 3).  
 
INSERT TABLE 2 AND INSERT FIGURE 3 ABOUT HERE 
 
Glucose Regulation. The treatment x glucoregulatory efficiency interaction was 
nonsignificant for all recall phases of the CVLT-II.  
 Basal HPA Axis Function.  Treatment x awakening free cortisol interactions were 
nonsignificant for all recall phases of the modified CVLT-II.     
 ASQ and Trait Anxiety. The treatment x stress interaction was nonsignificant for all 
recall phases of the CVLT. However, a significant treatment x trait anxiety interaction effect 
was observed on short delay free recall, F(1, 32) = 4.16, p = .05, and on long delay cued 
recall, F(1, 31) = 4.37, p < .05. Post hoc Bonferroni adjusted pairwise t-tests revealed that for 
short delay free recall, memory performance was significantly better in the glucose condition 
relative to the placebo condition only for those participants with relatively higher self-
reported trait anxiety, t (17) = 3.19, p < .05. Likewise, for long delay cued recall, post-hoc 
Bonferroni adjusted pairwise t-tests revealed that memory performance was significantly 
better in the glucose condition relative to the placebo condition only for those participants 
with relatively higher self-reported trait anxiety, t (17) = 3.41, p = .01 (see Table 3). 
 
INSERT TABLE 3 ABOUT HERE 
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DISCUSSION 
 The present study aimed to replicate previous work from our laboratory which 
suggests that the ingestion of oral glucose facilitates verbal episodic memory in healthy 
adolescents under conditions of divided attention at encoding (Smith and Foster, 2008a). 
Further, the hypothesis that individual differences in basal HPA axis function, self-reported 
stress and trait anxiety modulates the GMFE was investigated in the present study. Healthy 
adolescent males completed self-report measures of adolescent stress and trait anxiety. 
Awakening salivary free cortisol was also measured on up to three different mornings prior to 
memory testing. Participants presented for memory testing on two different occasions 
subsequent to an overnight fast. Encoding of memory test materials took place 
simultaneously with a secondary motor task, which was preceded by ingestion of either a 
glucose or placebo control solution. As anticipated, blood glucose concentration was 
significantly elevated subsequent to glucose ingestion for the glucose condition, relative to 
the placebo condition. 
 In accordance with previous findings concerning the GMFE, participants exhibited 
superior performance on the short delay free recall, long delay free recall and long delay cued 
recall phases of the modified version of the CVLT-II subsequent to ingestion of the glucose 
treatment relative to placebo. The rate of learning was also shown to be faster in the glucose 
condition relative to placebo, with participants demonstrating significantly enhanced 
performance on the fourth and fifth trials of the immediate free recall phase of the modified 
CVLT-II subsequent to glucose ingestion. Further, the present study findings suggest that the 
facilitatory influence of glucose on memory encoding can be observed one week post-
encoding, on the basis of the one-week free recall test in which more items were forgotten 
when the placebo had been administered prior to encoding, relative to glucose. Scores on the 
Bond-Lader scale did not differ significantly between the two treatment conditions, implying 
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that the observed treatment effects on memory were not influenced by fluctuations in mood 
or satiety across the testing sessions. This is despite a recent finding by Scholey and 
colleagues (Scholey et al., 2009) which reported an increase in self ratings of hunger 
subsequent to ingestion of a placebo drink relative to a glucose treatment. However, in this 
previous study, ingestion of the placebo drink was associated with increased hunger only 
under single-, but not dual-task conditions (Scholey et al., 2009). 
 The finding that glucose ingestion prior to encoding enhanced memory when retrieval 
took place one week later is in line with previous reports that glucose improves memory 
when glucose administration and encoding take place 24 hours prior to retrieval (Manning et 
al., 1992; Manning et al., 1998b; Sünram-Lea et al., 2002a). Such findings support the notion 
that glucose enhances memory encoding and/ or consolidation, rather than retrieval, as under 
these conditions glucose would have been cleared from the bloodstream by the time of 
memory retrieval. The one week delayed recall finding of the present study extends these 
previous study results (Manning et al., 1992; Manning et al., 1998b; Sünram-Lea et al., 
2002a) by a) suggesting that the effect of glucose on memory encoding lasts at least one 
week, and b) demonstrating that the effect of glucose on ‘extra-long’ delayed recall can be 
generalised to healthy adolescents. It is of further interest that the observed trend towards 
significantly reduced forgetting in the glucose condition, relative to the placebo condition 
was evident only for free recall and did not extend to cued recall. It can perhaps be inferred, 
on the basis of this finding, that the recall cues provided to the participants during the one 
week cued recall phase triggered a memory benefit that could not be further facilitated by 
pre-encoding glucose administration. This finding may also be related to the notion that the 
GFME is associated with more effortful cognitive processing, as free recall was likely to have 
been more cognitively demanding for the participants than cued recall.    
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 In contrast to our previously reported finding that the GMFE is mediated by 
glucoregulatory efficiency in adolescents (Smith and Foster, 2008a), individual differences in 
glucoregulatory efficiency were not found to influence the enhancement effect of glucose on 
memory observed here. Further, individual differences in awakening salivary free cortisol 
and self-reported stress were not observed to influence the glucose enhancement effect in the 
present study. However, trait anxiety was found to mediate the effect of glucose on short 
delay free recall and long delay cued recall performance; for these two CVLT recall phases a 
glucose enhancement effect was observed only for those participants who reported relatively 
higher trait anxiety. While it is unlikely that this finding was mediated by the HPA axis, it is 
nevertheless of interest to discuss further the role of trait anxiety as a possible mediator of the 
glucose memory facilitation effect. 
 To our knowledge, the present study represents the first report that the GMFE is 
influenced by trait anxiety. Given that negative affective states are associated with memory 
impairment (McEwen and Sapolsky, 1995; Sala et al., 2004), this finding may be considered 
in line with previous reports that individuals who are not able to perform at their cognitive 
peak, such as clinical populations with memory deficits (Manning et al., 1998a; Pettersen and 
Skelton, 2000; Watson and Craft, 2004; Stone and Seidman, 2008) and healthy elderly 
individuals (Craft et al., 1994; Riby et al., 2004) are most sensitive to glucose enhancement 
of memory. The finding that individuals with relatively higher trait anxiety are most 
amenable to the GMFE would appear to have important implications for the body of research 
which has demonstrated a memory advantage for negative emotionally arousing stimuli (see 
Hamann, 2001), especially if endogenous blood glucose increases mediate this effect (Gold, 
1995). Although speculative, it may well be that individuals reporting high trait anxiety are 
relatively more sensitive to emotionally arousing stimuli, and therefore exhibit relatively 
better memory for such items. This suggestion should be investigated further in future 
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studies. Likewise, the possible neurohormonal interactions underlying the relationship 
between trait anxiety, blood glucose increases and memory warrant further investigation. 
However, it appears unlikely that resting HPA axis activity is involved in subserving this 
relationship given the negative correlation between awakening salivary cortisol and trait 
anxiety observed in the present study. With respect to the extant literature, the relationship 
between trait anxiety and HPA axis function remains somewhat uncertain, however it has 
been reported that trait anxiety mediates the cortisol response to stress (Schlotz et al., 2006). 
Nevertheless, it is likely that the observed trait anxiety findings of the present study are 
subserved by a physiological mechanism, perhaps related to the SAM axis. It would therefore 
be of interest to investigate in future studies whether basal SAM function modulates the 
GMFE, although it is difficult to obtain robust biomarkers underlying basal SAM axis 
function.  
 As mentioned above, glucoregulatory efficiency was not observed to mediate the 
GMFE in the present study. Other researchers have reported that healthy young individuals 
with relatively poor glucoregulatory efficiency are more amenable to the GMFE (Craft et al., 
1994). This finding (Craft et al., 1994) is in line with the aforementioned notion that glucose 
enhancement of memory is most reliably observed in individuals who are not performing at 
their cognitive peak (given that poor glucoregulatory efficiency is associated with relatively 
poorer memory, Awad et al., 2002; Lamport et al., 2009). Nevertheless, as previously noted, 
there are some inconsistencies between studies regarding the direction of the relationship 
between glucoregulatory efficiency and glucose enhancement of memory. Specifically, it has 
been suggested that the influence of glucoregulatory efficiency on the GMFE is dependent on 
age, with Craft and colleagues (1994) reporting that glucose enhances memory in older 
individuals with relatively better glucoregulatory efficiency but in younger individuals with 
relatively poorer glucoregulatory efficiency. However, this framework is inconsistent with 
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the findings of a previous study from our laboratory in which the GMFE was observed only 
in adolescents exhibiting relatively better glucoregulatory efficiency (Smith and Foster, 
2008a). This discrepancy may be explained by the fact that the method typically employed to 
determine glucoregulatory efficiency is to perform a median split on some measure of 
glucose response. Due to the relatively small sample size of most studies in this area, the 
definition of ‘good’ and ‘poor’ glucose regulation can vary drastically between studies due to 
this method of establishing groups on the basis of glucoregulatory efficiency.  We have 
suggested previously that given the inverted-U shaped dose-response curve purported to 
underlie the GFME (Parsons and Gold, 1992), this disparity between studies in defining 
‘good’ versus ‘poor’ glucose regulation may lead to variation between studies with regard to 
whether the blood glucose concentration of the ‘poorer glucoregulators’ or ‘better 
glucoregulators’ (as defined by the individual studies) is within the optimal range to induce a 
memory improvement (Smith and Foster, 2008a). The role of glucoregulatory efficiency in 
mediating the GMFE merits further attention in future research investigations. This is a 
particularly important consideration in the context of better understanding the mechanisms 
underlying the GMFE, especially in situations in which proposed mechanisms (such as HPA 
axis function in this case) are influenced by glucoregulatory efficiency.  
 It was hypothesised prior to the present study that basal HPA axis function would 
modulate the glucose enhancement effect, predicated by the established relationship between 
glucoregulatory efficiency and HPA axis function (Plat et al., 1996; Reynolds et al., 2001; 
Andrews et al., 2002; Gibson, 2007). However, as mentioned above, the findings of the 
present study indicated that glucoregulatory efficiency, measured by calculating the AUC for 
each participant, did not influence the GMFE. In this context, it is perhaps unsurprising that 
awakening salivary free cortisol was not observed to modulate the effect of glucose on 
memory in the present study. This may in part be due to the fact that the adolescent 
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participants who took part in the present study represent a relatively healthy sample of 
individuals. In order to comprehensively address this question in future studies, it would be of 
interest to include more participants who exhibit glucoregulatory and/or HPA axis profiles 
outside of the normal range. 
In summary, the present study supported previous work from our laboratory that 
glucose can facilitate memory in healthy adolescents (Smith and Foster, 2008a; Smith and 
Foster, 2008b). Under conditions of divided attention, glucose ingestion was observed to 
enhance the rate of learning and delayed recall of a supraspan word list. Neither 
glucoregulatory efficiency nor basal HPA axis function were found to modulate the GMFE. 
However, individual differences in trait anxiety were observed to influence the enhancement 
effect of glucose on memory. These findings offer further support to the notion that glucose 
facilitation of memory is most reliably observed in individuals who are not able to perform at 
their cognitive peak, and suggest that the biological mechanisms underlying trait anxiety may 
modulate the GMFE. 
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Table 1 
The study procedure (the time in minutes of each procedure prior/subsequent to treatment 
delivery is displayed in the left column). 
t (mins) Procedure 
-15 One-week delayed recall (second testing session only) 
-10 First blood glucose measurement 
First modified Bond-Lader scale 
0 Treatment administration 
10 Second blood glucose measurement 
Second modified Bond-Lader scale 
20 CVLT-II Immediate free recall trials with secondary motor task 
40 Third blood glucose measurement 
Third modified Bond-Lader scale 
50 CVLT-II Short delay recall 
60 Fourth blood glucose measurement 
Fourth modified Bond-Lader scale 
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Table 2 
CVLT-II delayed recall results for the glucose and placebo conditions. Mean values are 
displayed, with standard deviations in parentheses. Repeated measures ANOVA revealed a 
significant difference in the total number of items recalled between the glucose and placebo 
conditions for the short delay free recall, long delay free recall and long delay cued recall 
phases. 
Modified CVLT-II recall phase Glucose Placebo p N 
Short delay free recall 14.0 (3.3) 12.7 (4.6) < .05 34 
Short delay cued recall 14.2 (3.0) 13.9 (4.4) 0.65 34 
Long delay free recall 14.4 (3.2) 13.3 (4.4) < .05 32 
Long delay cued recall 14.8 (3.2) 13.7 (4.4) < .05 33 
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Table 3 
CVLT-II delayed recall results for the glucose and placebo conditions, arranged by relative trait anxiety. Mixed model ANOVAs and Bonferroni 
adjusted post-hoc pairwise t-tests revealed a significant difference between the number of items recalled in the glucose and placebo treatment 
conditions only for those participants reporting relatively higher trait anxiety, at the short delay free recall and long delay cued recall phases. 
 Low Trait Anxiety   High Trait Anxiety  
Modified CVLT-II recall phase Glucose Placebo p  Glucose Placebo p 
Short delay free recall* 14.1 (3.6) 14.0 (4.7) n.s.  13.8 (3.2) 11.5 (4.4) < .05 
Short delay cued recall 14.1 (3.2) 14.8 (3.9) -  14.2 (3.0) 13.2 (4.7) - 
Long delay free recall 15.0 (3.4) 14.6 (4.3) -  13.9 (3.2) 12.3 (4.3) - 
Long delay cued recall* 15.0 (3.5) 14.9 (4.2) n.s.  14.6 (3.1) 12.7 (4.4  .01 
Treatment x Trait Anxiety Interactions: *p ≤ 0.05




Blood glucose concentrations (mean ± SE) for the glucose and placebo treatment conditions 
at each measurement time point (N=40). Repeated measures ANOVA and planned 
comparisons revealed that blood glucose concentration was higher for the glucose condition, 




Total items recalled (mean ± SE) on trials 1-5 of the Immediate Free Recall phase of the 
CVLT-II. Repeated measures ANOVA and planned comparisons revealed that a significantly 
greater number of items was recalled subsequent to glucose ingestion, relative to placebo 
ingestion, on trial 4 and trial 5 (N=32). 
 
Figure 3 
Total items forgotten (mean ± SE) between the Long Delay Recall phase in the first testing 
session, and the one-week delayed recall phase of the second testing session for the glucose 
and placebo treatment conditions (i.e. the treatment administered in the first testing session). 
One-way ANOVA revealed a trend toward greater ‘forgetting’ in the free recall phase for the 
placebo condition, relative to the glucose condition, one-week post-encoding. 
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